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Abstract
A reporter plasmid pSRG has been developed which expresses red fluorescent protein (RFP) from a constitutive prokaryotic
promoter within Pasteurella multocida B:2 and green fluorescent protein (GFP) from a constitutive eukaryotic promoter
within mammalian cells. This construct has been used to determine the location and viability of the bacteria when moving
from the extracellular environment into the intracellular compartment of mammalian cells. Invasion assays with embryonic
bovine lung (EBL) cells and an attenuated AroA- derivative of Pasteurella multocida B:2 (strain JRMT12), harbouring the
plasmid pSRG, showed that RFP-expressing bacteria could be detected intracellularly at 3 h post-invasion. At this stage,
some EBL cells harbouring RFP-expressing bacteria were observed to express GFP simultaneously, indicating release of the
plasmid into the intracellular environment. At 5 h post-invasion, more EBL cells were expressing GFP, while still harbouring
RFP-expressing bacteria. Concurrently, some EBL cells were shown to express only GFP, indicating loss of viable bacteria
within these cells. These experiments proved the functionality of the pSRG dual reporter system and the potential of P.
multocida B:2 JRMT12 for bactofection and delivery of a DNA vaccine.
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Introduction
The numerous serotypes of Pasteurella multocida are associated
with a variety of disease syndromes in a wide range of agricultural,
domestic and feral animal species [1]. P. multocida serotypes B:2
and E:2 are associated with haemorrhagic septicaemia (HS) of
cattle, water buffaloes and occasionally other species, resulting in
major economic losses, mainly in South East Asia [2,3]. Several
types of killed, whole-cell vaccines have been used for prevention
and control of the disease including alum-precipitated vaccine and
oil-adjuvant vaccine but, in general, immunity is short-lived.
Countries where the disease is endemic resort to routine
prophylactic vaccination. A live-attenuated vaccine for HS might
be a better alternative vaccine as, by mimicking the ability of the
pathogen to infect the host, but without causing disease, a more
prolonged protective immune response may be induced. A live-
attenuated vaccine developed by Tabatabaei et al. [4], by mutating
a housekeeping gene aroA, proved to be highly attenuated yet
protective in mice and in cattle [4–6]. In later work, Othman et al.
[7] reported on the ability of the live vaccine strain to adhere to
and to invade embryonic bovine lung (EBL) cells with an efficiency
similar to the wild-type strain. The live vaccine strain was also able
to survive intracellularly in the EBL cells for at least 7 hours.
The long term aim of the present work is to exploit the capacity
of the live P. multocida aroA vaccine strain to invade mammalian
cells in order to deliver plasmid DNA encoding a protective
antigen for another disease of the target animal, thus providing
heterologous protection against both HS and a second disease.
Bactofection, bacteria-mediated transfer of expressible DNA, is a
promising approach to express plasmid-encoded heterologous
proteins in different cell types, including phagocytic and non-
phagocytic mammalian cells. Various studies have demonstrated
bactofection with attenuated strains of invasive bacteria. For
example, vaccination of mice with attenuated Salmonella typhimurium
transformed with plasmid DNA encoding listeriolysin (a virulence
factor of Listeria monocytogenes) induced specific antibody as well as
T-cell responses to listeriolysin [8]. In a separate study, fluorescent
dendritic cells (DC) were demonstrated after oral administration of
S. typhimurium harboring plasmid DNA encoding green fluorescent
protein (GFP). These data provided evidence that this delivery
system could target relevant immune cells, leading to efficient
induction of an immune response [9]. Mice vaccinated with an
attenuated Shigella vaccine harbouring measles virus genes induced
a vigorous measles virus antigen-specific response [10]. An
attenuated L. monocytogenes strain has also been used for delivery
of eukaryotic expression vectors to the cytoplasm of murine
macrophage cell lines [11]. This technology has also been
demonstrated with a plant pathogen, Agrobacterium tumefaciens,
which contains a virulence plasmid that promotes transfer of an
expression cassette from the plasmid into the plant. Although
wounded plants are its natural targets, plasmid transfer by A.
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tumefaciens has also been demonstrated to yeast and fungi. In vitro, it
can also target human cell lines such as HeLa cells [12]. These
reports clearly demonstrate bacterial versatility as delivery vectors.
As this approach has not previously been used with Pasteurella, we
have developed a bactofection model system for use with this
organism that employs a dual-expression plasmid for protein
expression in both prokaryotic and eukaryotic cells in order to
understand the fate of the plasmid DNA carrying antigenic genes
after delivery by the live-vaccine strain in vivo.
Materials and Methods
Bacterial Strains and Growth Conditions
Bacterial strains used in this study were: P. multocida B:2
JRMT12, an aroA deletion mutant of P. multocida strain 85020 [4]
and E. coli XL-1BLUE (Amersham Biosciences). P. multocida was
grown on Brain Heart Infusion (BHI) agar or in BHI broth (Difco)
media and E. coli was grown on Luria-Bertani (LB) agar or in LB
broth (Difco) media at 37uC and shaken at 180 rpm.
Plasmids
Plasmid pMK-Express [13] is a broad-host range plasmid that
can propagate in HAP (Haemophilus, Actinobacillus & Pasteurella)
bacteria. An A. pleuropneumoniae promoter, Psod-C, was incorpo-
rated into plasmid pMK-Express upstream of the gfpmut3 gene
coding for GFP. This constitutive promoter was able to express the
GFP protein in Pasteurella [13]. Plasmid pDsRed-Monomer
(Clontech) encodes red fluorescent protein (RFP) from the DsRed
fragment. Plasmid pEGFP-N1TM (Clontech) encodes green
fluorescent protein (GFP) from a constitutive eukaryotic promoter
PCMVIE and is able to replicate in E. coli and eukaryotic cells.
General Molecular Biology Techniques
Plasmid extractions were performed using Qiaprep spin
columns (Qiagen). DNA concentrations were measured using a
NanoDrop ND-1000 UV-visible spectrophotometer (NanoDrop
Technologies). Unless otherwise stated, restriction enzymes were
obtained from New England Biolabs and used according to the
manufacturer’s protocol. PCR was performed according to
standard procedures [13,14] using Taq DNA polymerase
(NEB,UK). RED primers with internal PciI sites (bold fonts)
(RED Forward: 59- CTACATGTCCGCGCCAACCG 239,
RED Reverse: 59- GCACATGTTCTACTGGGAG -39) were
used to amplify the PsodC-DsRed fragment from plasmid pMK-
RED. A MegaBACE1000 (96 capillary) sequencer, which used Big
Dye (Applied Biosystems) and ET-Dye Terminator (Amersham
Bioscience) chemistries, was employed for DNA sequencing. The
sequencing was done by The Sequencing Unit, University of
Dundee, Scotland.
Plasmid Transformation
An overnight culture of P. multocida grown in BHI broth was
diluted 1 in 100 into 500 ml of pre-warmed BHI broth and grown
at 37uC to an optical density at 600 nm (OD600nm) of 0.5–0.7
measured using a cell density meter (WPA CO8000, Biochrom
Ltd.). The cells were harvested by centrifugation and then made
electrocompetent by concentrating 100-fold and washing three
times with ice-cold 10% (v/v) glycerol before suspension in ice-
cold 10% (v/v) glycerol. Electrocompetent cells (50 ml) plus 10–
200 ng of PCR product, plasmid or ligation mixture were used.
After mixing, electroporation was done with a Bio-Rad pulse
controller (MicroPulser Electroporator, Bio-Rad) set at 2.5 kV
(field strength 12.5 kV/cm2). Shocked cells were added to 1 ml of
BHI and incubated at 37uC for 4 h. Aliquots of 50–100 ml of
transformed cells were then spread onto selective plates containing
appropriate antibiotics and the plates were incubated at 37uC to
obtain transformant colonies.
For E. coli, plasmid DNA was transformed into E. coli XL-
1BLUE using the heat shock protocol specified by the manufac-
turer (Amersham Biosciences).
Preparation of Embryonic Bovine Lung (EBL) Cells
EBL cells (German Collection of Microorganisms and Cell
Cultures, no. ACC192) were grown as a monolayer in Minimal
Essential Medium (MEM 2279, Sigma) containing streptomycin
(100 mg/ml), penicillin (100 U/ml) and 15% (v/v) foetal calf
serum (FCS, Sigma) in a humidified atmosphere of 5% (v/v) CO2
and 95% (v/v) air at 37uC. Cells taken from liquid nitrogen stock
were cultured for two days before seeding into a 24-well tissue-
culture plate and incubated overnight.
EBL Cell Viability Assessment
The trypan blue exclusion method was used. A mixture
containing 10 ml of trypan blue (0.4% w/v) (Sigma) and 10 ml of
the cell suspension was placed in an improved Neubauer (1/400
mm260.1 mm depth) chamber and viewed with a light micro-
scope and a610 objective lens. Cells stained blue were counted as
dead whereas clear cells were counted as viable.
P. multocida Invasion of EBL Cells
This was done as previously described (Othman et al., 2012)
(N.B. ref [7]). Briefly, bacteria were harvested from 18-h
cultures in BHI broth, washed twice in phosphate-buffered
saline (PBS) and suspended in MEM without antibiotics. The
bacterial suspension was adjusted to an OD600nm corresponding
to approximately 16107 colony forming units (CFU)/ml to
allow a final multiplicity of infection (MOI) of 100 bacteria/
mammalian cell. Previous work had shown this to be the
optimum MOI in our system (7). The concentration of viable
EBL cells in one well of a 24-well tissue culture plate was
assessed by trypan blue and bacterial suspension was then
added at the appropriate concentration to each well containing
EBL monolayer. The plate was centrifuged at 12006g for
5 min in a Heraeus 3 S-R centrifuge to encourage close contact
between the EBL and bacterial cells. After incubation in a CO2
incubator at 37uC for 2 h, the wells were washed gently with
PBS to remove the unattached bacteria. The washing step was
repeated twice. One millilitre of MEM with antibiotics
[polymyxin (50 mg/ml) and gentamicin (50 mg/ml)] was added
to each well and the plate was incubated for 1 h at 37uC in 5%
(v/v) CO2 to kill any remaining extracellular bacteria. The wells
were then washed twice with PBS to remove the antibiotics
before further manipulation.
Assessment of RFP and GFP Expression in Bacteria
This was monitored using a fluorimeter (FLUOstar OPTIMA,
BMG Labtech). BHI broth (100 ml), supplemented with appro-
priate antibiotics at a final concentration of 50 mg/ml, was
inoculated with 1 ml of an overnight culture of P. multocida B:2 or
E. coli XL-1BLUE and shaken at 180 rpm, 37uC. At hourly
intervals, 1 ml samples of culture were taken and the OD600nm was
measured. The suspension was then centrifuged at 13 000 x g for
1 min and the pellet resuspended in 1 ml of PBS. The OD600nm
was measured again with PBS as standard and 200 ml aliquots
placed in wells of a 96-well flat-bottom dish (Corning, USA) in
triplicate. The fluorescence intensity (FI) at 550 nm for GFP and
590 nm for RFP was measured in the fluorimeter with a
Bactofection and P. multocida B:2
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fluorescent light filter and excitation at 490 nm and 520 nm,
respectively. All samples were compared with bacteria without
plasmids to eliminate background fluorescence. Samples were
taken at hourly intervals until the OD600nm reached stationary
phase (,2.0). Control experiments showed negligible expression of
GFP in P. multocida JRMT12 throughout the growth cycle,
indicating that the PCMVIE promoter was not able to drive
transcription of GFP in this prokaryotic background.
Fluorescence Imaging
Fluorescent staining of EBL cells. EBL cells were treated
according to the invasion assay above. The only difference for
fluorescence microscopy (FM) slide preparation was that the EBL
cells were seeded in a chamber-slide (NUNC) rather than a 24-well
plate, so that cells could be fixed directly to the slide after
removing the well from the chamber slide.
After antibiotic treatment to eliminate extracellular and
adherent bacteria, the monolayer was washed twice with PBS.
CellMask plasma membrane stain (GE Healthcare) (5 mg/ml)
(diluted according to manufacturer’s instructions) was added at
200 ml per well. The chamber-slide was then incubated for 7 min
at 37uC in an atmosphere supplemented with 5% (v/v) CO2. The
staining solution was removed from the well and the cells washed
three times with PBS. Pre-warmed paraformaldehyde (PFA)
200 ml at 4% (v/v) was added to each well and slides incubated
for 30 min at 37uC in an atmosphere supplemented with 5% (v/v)
CO2. PFA was then removed and cells were washed three times
with PBS. The wells were then removed from the chamber-slide
and the slide was left to dry.
Fluorescence mounting medium (DAKO) was used to cover the
fixation area on the chamber-slide. A cover slip was then gently
applied on top of the medium to avoid air bubble formation. Any
gap between the cover slip and the chamber-slide was then sealed-
off using nail varnish to prevent air pockets from forming. The
slide was left for 10 min to allow the mounting medium to set. It
was then cleaned and labelled before storage in the dark.
Fluorescent Staining of Bacteria
Bacteria were grown in BHI broth with vigorous shaking at
37uC until an OD600nm of 0.3–0.5 was obtained. One millilitre of
bacterial suspension was taken and centrifuged at 13 0006g for 1
minute. The pellet was resuspended in 1 ml of PBS and the
OD600nm was measured. An aliquot of 200 ml was transferred from
the PBS suspension into a flat-bottom 96-well plate. All samples
were done in triplicate. Fluorescence intensity (FI) of RFP was then
measured.
A vial of Cye5Dye (Amersham Bioscience) was mixed with
100 ml of PBS according to the manufacturer’s instructions and
the dye was then mixed with bacterial suspension at a ratio of 1:20
(25 ml of dye to 500 ml of bacterial suspension). The mixture was
then incubated in the dark at room temperature for 1 h to allow
staining of bacterial free-peptide groups on the outer membrane.
After incubation, the suspension was pelleted at 13 0006g for
1 min and washed with 1 ml of PBS before being re-centrifuged.
The washing step was repeated until the suspension was no longer
coloured.
For fixation, an aliquot of the suspension was mixed (1:1) with
4% (v/v) PFA. About 20 ml of the fixation mixture was spotted
onto a clean spot-slide which was then left at room temperature to
dry. Fluorescence mounting medium (DAKO) was used to cover
the fixation area on the spot-slide and the slides prepared for
storage as described.
Fluorescence Microscopy (FM)
Fluorescence imaging was done with a Zeiss AxioImager M1
upright fluorescence microscope (Carl Zeiss) connected to a
Hamamatsu Orca 03 and QIClick digital charge-coupled device
(CCD) camera. The system allows visualization of fluorescence at
high spatial resolution (120061300 pixels) and high bit depth (12-
bit gray scale). Acquisition, visualization, measurement and
restoration of the images were then processed with Volocity
software (Perkin Elmer).
Results
Construction of ‘‘traffic-light’’ Plasmid, pSRG
Fig. 1 shows the cloning strategy for the construction of pSRG.
First, plasmid pMK-RED was generated. It was derived from
plasmid pMK-Express [13] and contained the DsRed fragment
from pDsRed-Monomer (Clontech). The gfpmut3 gene from pMK-
Express was removed by digestion with BamHI and NotI and
replaced by the DsRed fragment cut from pDsRed-monomer to
produce pMK-RED (Fig. 1A). Plasmid pMK-RED was then used
as a template for PCR with RED primers to amplify the PsodC-
DsRed fragment with PciI sites at each end. This amplimer was cut
with PciI and cloned into the unique PciI site of pEGFP-N1
(Fig. 1B, C). Ligation of this fragment into pEGFP-N1 was
performed at a ratio of 1:2 (plasmid:fragment) to obtain plasmid
pSRG (Fig. 1D). The ligation mixture was then transformed into
E. coli XL-1BLUE. Plasmid pSRG was purified using Qiaprep
Spin Miniprep Kit (Qiagen) according to manufacturer’s instruc-
tion and confirmed by restriction enzymes digestion.
After that, pSRG was electroporated into P. multocida B:2
JRMT12 and positive transformants were selected on BHI agar
supplemented with kanamycin (50 mg/ml). A strain harbouring
pSRG was assessed for plasmid stability after repeated subculture.
P. multocida B:2 JRMT12 pSRG was plated on BHI agar with and
without kanamycin (50 mg/ml). After incubation for 24 h, selected
colonies from both plates were streaked to fresh plates. After a
further 24 h, a dozen colonies were picked from both plates and
inoculated into BHI broth with or without kanamycin (50 mg/ml)
respectively. After 24 h, plasmids were purified and analysed by
restriction digestion with PciI for confirmation of their identity.
Strains were subcultured daily into fresh broth medium for 14 days
and plasmids from each culture were purified and analysed every
alternate day. After 14 days, P. multocida B:2 JRMT12 pSRG
cultured without antibiotic was found to be still harbouring the
plasmid in each of the 12 clones subcultured. Thus, pSRG was
stably maintained in P. multocida B:2 JRMT12 in the absence of
antibiotic.
Expression of RFP from pSRG in P. multocida B:2 JRMT12
Figure 2 (I) shows the fluorescence intensity (FI) in relative
fluorescence units (RFU) of P. multocida B:2 JRMT12 pSRG
plotted against bacterial density (OD600nm). Immediately after
inoculation into BHI broth, at OD600nm 0.07, the strain was
clearly expressing RFP (FI .2500 RFU). This fluorescence
decreased initially but then increased with increasing bacterial
density, to .3000 RFU when the OD600nm had reached 0.79.
After that, the RFP expression was seen to decline. The results
indicated that the RFP expression from this strain peaked in the
late exponential phase of growth.
Visualization of RFP Expression from P. multocida B:2
JRMT12 pSRG via Fluorescence Microscopy (FM)
The bacteria were cultured as described before, and sampling
was done between OD600nm 0.7 and 0.8 in order to capture the
Bactofection and P. multocida B:2
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bacteria during maximum RFP expression. After confirming RFP
expression, in the fluorimeter, bacteria were prepared for
microscopy.
In Figure 2 (II), a set of images was captured from the spot slide
prepared with P. multocida B:2 JRMT12 pSRG taken at OD600nm
0.79. Images were taken of the same field using the 1006objective
lens under three different light paths to ease visualization. Image
A, taken under DIC (Differential Interference Contrast) (white)
light, showed a heavy cluster of bacteria. When the same field of
the slide was captured in B, where the image was taken under
filtered fluorescent light (Excitation = 649 nm, Emis-
sion= 670 nm) (blue) to visualize the counterstain Cy5 Dye, the
bacteria were more defined. This image was taken at 0.6 mm
splicing through the slide in order to view a single layer of the
bacteria. The slide was set to be sectioned optically at 0.3 mm
intervals from top to bottom; an image was captured at every
0.3 mm depth at a total section stacking of 3.0 mm. The Volocity
software was then utilized to deconvolve images captured by
reversing the optical distortion to produce a sharper and clearer
image. This technique also eliminated background light diffrac-
tion. Image C was taken under filtered fluorescent light
(Exc. = 557 nm, Ems. = 585 nm) (red) to visualize bacteria ex-
pressing RFP from plasmid pSRG and under filtered fluorescent
light (Exc. = 649 nm, Ems. = 670 nm) (blue) to show the counter-
stain in order to localize the RFP expression in the bacteria. The
image showed purplish pink coccobacilli of P. multocida B:2
JRMT12 pSRG expressing RFP. Image D shows a 3-dimensional
(3D) image of image C to generate a 3D model of the RFP-
expressing bacteria. The vertical elongated shape of the bacteria is
presumed to be an artefact of iterative restoration after image
manipulation using Volocity software.
Intracellular Trafficking of P. multocida B:2 JRMT12 pSRG
within EBL Cells
EBL cells and bacteria were prepared as above but with the
modification that the bacterium, P. multocida B:2 JRMT12 pSRG,
was grown to OD600nm 0.79 (at maximum RFP expression) before
use in the invasion assay. Slides were prepared for FM and viewed
under the x100 objective lens of the Zeiss AxioImager M1
microscope (Carl Zeiss).
Five sets of images are displayed in Figure 3. Sets A and B were
captured from slides prepared after the standard invasion time of
3 h, while sets C and D were captured from slides prepared at 5 h
post-invasion. All images in a set were captured in the same field of
the slides but under different light paths. In set A, the first image (i)
shows a single EBL cell taken under DIC (white) light. Under blue-
filtered fluorescent light, the plasma membrane was stained blue
(ii). An overlay of blue- and red-filtered fluorescent light showed
the cell membrane as blue and the internalized P. multocida B:2
JRMT12 pSRG as red (iii). The 3D image (iv) displayed was
generated from the 2D image using Volocity software. However,
when the fluorescent light path was changed to green to visualize
GFP, no green fluorescence was found to be expressed by this EBL
cell (not shown). Hence, at 3 h post-invasion, internalized bacteria
were found in this EBL cell but no expression of GFP was
detected. This indicated that the bacteria were still intact and had
not released plasmid into the intracellular environment of the EBL
cell.
Figure 1. Construction of the ‘‘traffic light’’ reporter plasmid, pSRG. (A) Plasmid pMK-RED was constructed from plasmid pMK-Express [13]
containing the DsRed.M1 gene from plasmid pDsRed-Monomer (Clontech) inserted between the BamHI and NotI sites in place of the gfpmut3 gene.
(B) Eukaryotic expression plasmid pEGFP-N1TM (Clontech) was digested with PciI. (C) Amplification of the PsodC-DsRed fragment with RED primers
containing PciI sites. (D) Plasmid pSRG with two expression systems, a red reporter system that functions in prokaryotic cells driven by the sodC
promoter and a green reporter system that functions in eukaryotic cells driven by the PCMVIE promoter.
doi:10.1371/journal.pone.0071524.g001
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As in set A, images in set B were also captured at 3 h post-
invasion. In this set, again a single EBL cell is clearly defined under
the DIC (white) light (i) and filtered fluorescent blue light
demonstrated the EBL cell membrane in blue when stained by
the plasma membrane stain CellMask (ii). Under red and blue
filtered fluorescent light, RFP expression (red) was visualised as in
image A (iii). By switching the filtered fluorescent light path into
green and blue, the EBL cell was seen to express GFP within the
cell cytoplasm (iv). 3D images (v & vi) were then generated from
the 2D images using the Volocity software. The data could be
interpreted to indicate that, in this EBL cell, free plasmid was
available for expression of GFP in the cytoplasm of the cell. The
presence of fewer RFP-expressing bacteria within this cell might
mean that others had been lysed so that they were no longer able
to express RFP but had released plasmid into the cytoplasm to
generate GFP. The obvious presence of bacteria at the periphery
of the EBL cell, expressing RFP, might indicate that these bacteria
had not yet been taken up by the cell but had nevertheless resisted
washing and antibiotic treatment.
Seventy EBL cells were assessed for RFP or GFP expression
from slides prepared at 3 h post-invasion. Of these cells, 39 (56%)
were found not to be expressing GFP and no RFP-expressing
bacteria were found intracellularly. The remaining 31 (44%) EBL
cells were found to harbour a number of RFP-expressing P.
multocida B:2 JRMT12 pSRG intracellularly and, of these, 12 (17%
of total) EBL cells were already expressing GFP. No EBL cells
expressing GFP without harbouring RFP-expressing bacteria were
found at this stage.
Images in sets C and D were captured at 5 h post-invasion. In
set C, under DIC (white) light, a single EBL cell on a monolayer
was captured (i). When viewed under filtered fluorescent blue light,
the labelled EBL membrane boundaries were visible as a blue
fluorescence (ii). When viewed with red and blue filtered
fluorescent light paths, the image showed some internalized
bacteria (red) within membrane boundaries (blue) (iii). Green and
blue fluorescent light paths showed green fluorescence in the EBL
cell cytoplasm within membrane boundaries (blue) (iv). Both 2D
images were then processed with Volocity software to generate
their respective 3D images. In these, localization of RFP (v) and
GFP (vi) expression was clearly displayed within the labelled (blue)
membrane boundaries.
Figure 2. (I) Assessment of RFP expression by P. multocida B:2 JRMT12 pSRG during growth. P. multocida B:2 JRMT12 without plasmid
acted as a control for background fluorescence. Fluorescence was plotted against OD600nm using Microsoft Excel software and data were corrected
for background fluorescence. Experiments were performed in triplicate and the error bars indicate standard deviations of the means. (II)
Visualization of P. multocida B:2 JRMT12 pSRG via fluorescence microscopy. Images of P. multocida B:2 JRMT12 pSRG were taken of the
same field under three different light paths; A: DIC (white) light, B: filtered fluorescent light (Exc. = 649 nm, Ems. = 670 nm) (blue) to visualize the
counterstain, Cy5 Dye (Amersham Bioscience), C: two filtered lights; filtered fluorescent light (Exc. = 557 nm, Ems. = 585 nm) (red) to visualize bacteria
expressing RFP from plasmid pSRG and filtered fluorescent light (Exc. = 649 nm, Ems. = 670 nm) (blue) to visualize the counterstain, Cy5 Dye in order
to show that RFP expression was within the bacteria, D: 3D imaging of the 2D image from C using Volocity software.
doi:10.1371/journal.pone.0071524.g002
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Set D images, captured at 5 h post-invasion, show a single EBL
cell taken under DIC (white) light (i) and the same cell viewed
under filtered fluorescent blue light revealed the labelled cell
membrane (ii). Switching to both green and blue filtered
fluorescent light showed expression of GFP by the EBL cell,
displayed as green fluorescence within the cell membrane (blue)
(iii). The 3D image (iv) was then generated from the 2D image
using Volocity software. When the cell was viewed under red and
blue filtered fluorescent light paths, the image showed only the
EBL cell with the membrane boundaries outlined in blue
fluorescence (image not shown). These data indicated that, at this
stage, internalized RFP-expressing bacteria had been lysed so that
they were no longer able to express RFP but had released the
plasmid into the EBL cytoplasm for GFP expression controlled by
the eukaryotic promoter.
As a negative control, EBL cells were infected with the JRMT12
strain harbouring pMK-RED (Figure 1), which expresses only
RFP. This control was analysed using the same microscopy
settings as for sets A–D. Panel E shows that internalised bacteria
were expressing RFP while the infected EBL cells emitted no
detectable green autofluorescence. This confirms the conclusion
that fluorescence measured in the GFP channel as in panels B-D
could only be attributed to expression from pSRG.
Sixty EBL cells were assessed from slides prepared at 5 h post-
invasion. Of these, 28 (47%) were found not to be expressing GFP
and no RFP-expressing bacteria were found intracellularly. Each
of the remaining 32 (53%) EBL cells were found to be expressing
GFP and of these, 12 (20% of total) cells were found to be still
harbouring some RFP-expressing P. multocida B:2 JRMT12 pSRG
intracellularly whereas the others expressed only GFP.
Images A (iii), B (iii) and C (iii) show the capacity of P. multocida
B:2 JRMT12 pSRG, internalised within EBL cells, to express RFP
from pSRG. RFP expression would have taken place within intact
bacteria, driven by the Psod-C promoter. Images B (iv), C (iv) and
D (iv) show the ability of EBL cells to express GFP from pSRG
which must have been released from the internalized P. multocida
B:2 JRMT12 pSRG in order for the eukaryotic promoter PCMV
IE to drive expression of GFP within the EBL cell cytoplasm. The
images also illustrate the variation in the timing of both RFP and
GFP expression with one cell showing RFP expression as late as
5 h post-invasion (image C) and another cell expressing GFP as
early as 3 h (images A and B). From observation of 70 EBL cells at
3 h post-invasion, three categories of EBL cells were found. Some
were found without any bacteria internally (no RFP expression),
some had internalized bacteria but the mammalian cells were not
expressing GFP and some, the lowest percentage, harboured
internalized viable P. multocida B:2 JRMT12 pSRG but at the same
time expressed GFP. Observation of 60 cells at 5 h post-invasion,
demonstrated three categories of EBL cells, some without any
bacteria internally, some harbouring internalized viable P.
Figure 3. Localization of prokaryotic and eukaryotic protein
expression. The images show EBL cells after invasion with P. multocida
B:2 JRMT12 pSRG. Images were captured at 3 h (A and B) and 5 h (C
and D) post-invasion. In A, an EBL cell was viewed (i) under DIC (white)
light, (ii) by counterstaining with CellMaskTM plasma membrane stain
(GE Healthcare) (blue), (iii) merged 2D images of (ii) and image captured
under filtered fluorescent light (Exc. = 557 nm, Ems. = 585 nm) (red) to
visualize internalized RFP-expressing bacteria and (iv) a 3D image of (iii).
In B and C, an EBL cell was viewed (i) under DIC (white) light, (ii) by
counterstaining with CellMaskTM plasma membrane stain (GE Health-
care) (blue), (iii) merged 2D images of (ii) and image captured under
filtered fluorescent light (Exc. = 557 nm, Ems. = 585 nm) (red), (iv)
merged 2D images of (ii) and image captured under filtered fluorescent
light (Exc. = 488 nm, Ems. = 507 nm) (green) to visualize expression of
GFP by the mammalian cells, (v) a 3D image of (iii) and (vi) a 3D image
of (iv). In D, an EBL cell was viewed (i) under DIC (white) light, (ii) by
counterstaining with CellMaskTM plasma membrane stain (GE Health-
care) (blue), (iii) merged 2D images of (ii) and image captured under
filtered fluorescent light (Exc. = 488 nm, Ems. = 507 nm) (green) and (iv)
a 3D image of (iii). The merged 3D images were included to
demonstrate the localization of either RFP or GFP expression.
Fluorescence emitted by EBL cells infected with JRMT12 strain
harbouring pMK-RED (E) with the same microscope settings, was used
as a negative control. Each cell was viewed (i) under DIC (white) light,
(ii) by counterstaining with CellMaskTM plasma membrane stain (GE
Healthcare) (blue), (iii) merged 2D images of (ii) and image captured
under filtered fluorescent light (Exc. = 557 nm, Ems. = 585 nm) (red) to
visualize internalized RFP-expressing bacteria and (iv) merged 2D
images of (ii) and image captured under filtered fluorescent light
(Exc. = 488 nm, Ems. = 507 nm) (green).
doi:10.1371/journal.pone.0071524.g003
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multocida B:2 JRMT12 pSRG expressing RFP while at the same
time expressing GFP, and some EBL cells without any RFP
expression but which expressed GFP. The last category was not
found at 3 h post-invasion and the second category of EBL cells
found at 3 h post-invasion was not found at 5 h post-invasion.
Taken together, these data present good evidence that P. multocida
B:2 JRMT12 can carry plasmid pSRG into EBL cells and, while
the bacteria remain viable, they will express RFP. Loss of RFP
expression at 5 h post-invasion plus expression of GFP would
indicate release of pSRG into the cytoplasm from the non-viable
bacteria, where the plasmid was able to express GFP from the
PCMVIE promoter.
Discussion
Bactofection (bacteria-mediated transfer of expressible DNA)
can be applied for genetic vaccination, gene therapy and
production of therapeutic proteins [15]. A development of the
work described here would be to apply bactofection to genetic
vaccination against cattle diseases. Hence, in this study, our aim
was to visualize trafficking of a potential delivery plasmid from P.
multocida B:2 into EBL cells using a plasmid able to propagate and
express a reporter protein in P. multocida and also to express a
reporter protein in mammalian cells. As outlined in Figure I, the
‘‘traffic-light’’ plasmid termed pSRG was designed with a
promoter, Psod-C, active in Pasteurella bacteria upstream of a
DsRed.M1 gene coding for RFP, together with the virally-derived
promoter, PCMVIE, for expression in eukaryotes, upstream of the
EGFP gene coding for GFP. pSRG, at 5700 bp, was successfully
propagated and maintained stably in the P. multocida B:2 strain
JRMT12 for at least 14 days without the presence of selective
antibiotic. Assessment of RFP expression through the bacterial
growth cycle showed that JRMT12, harbouring pSRG, expressed
RFP maximally during the late exponential phase. Fluorescence
microscopy showed P. multocida B:2 JRMT12 pSRG expressing
RFP from individual bacteria.
An invasion assay with P. multocida B:2 JRMT12 pSRG was
undertaken to demonstrate bacterial entry, plasmid release and
reporter protein expression within EBL cells. At 3 h post-invasion,
bacteria were seen intracellularly, along with RFP expression and
Figure 4. Bactofection pathway for DNA vaccine delivery. Yellow arrows indicate a schematic pathway for the bacterial plasmid delivery
process in EBL cells. After internalization of the bacteria and phagolysosome fusion, the escape of the plasmid DNA (pSRG) from the vacuole into the
cytosol after bacterial degradation results in the transfer of the pSRG to the intracellular environment of the EBL cell. Plasmid DNA then localises in
the nucleus (blue circle) to allow expression of the GFP gene by the eukaryotic promoter, which is followed by GFP formation in the cytosol (green
colouration in cytoplasm). Blue arrows point to microscopic images taken at different stages of the invasion assay; (A) P. multocida B:2 JRMT12 pSRG
expressing RFP. Bacteria counterstained with Cy5 Dye (blue). (B) EBL cell at 3h post-invasion showing intracellular P. multocida B:2 JRMT12 pSRG
expressing RFP. The EBL plasma membrane is counterstained blue. (C) Optical sectioning of the EBL cell in B at 0.3 mm intervals from top to bottom,
confirmed the intracellular location of the RFP-expressing bacteria. (D) EBL cell in B at 3h post-invasion showing intracellular P. multocida B:2 JRMT12
pSRG expressing RFP. (E) The same EBL cell in D expressing GFP from intracellular plasmid DNA. (F) EBL cell expressing GFP at 5h post-invasion with P.
multocida B:2 JRMT12 pSRG. Magnification x100; counterstaining with Cy5 Dye (blue) for bacteria and CellMask (blue) for EBL cells.
doi:10.1371/journal.pone.0071524.g004
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in some cells green fluorescence was localised only in the
cytoplasm and not in the nucleus. FM images suggested that, at
3 h post-invasion, RFP-expressing bacteria were found intracellu-
lary in EBL cells. Some of these cells were expressing GFP
indicating that bacterial lysis had occurred in some cases and
plasmid had been released into the cytoplasm. Images captured at
5 h post-invasion showed that some 20% of EBL cells still
contained viable P. multocida B:2 JRMT12 pSRG as demonstrated
by RFP expression. This confirmed findings of Othman et al [7],
on the intracellular survival of the live-vaccine strain, that viable
intracellular bacteria could be detected from 3–7 h post-invasion
although the number decreased with time. FM images at 5 h post-
invasion showed some EBL cells containing viable P. multocida B:2
JRMT12 pSRG were also expressing GFP, an indicator of
bacterial lysis and the presence of pSRG in the EBL cell
cytoplasm. The 3D images provided a better visualization of the
model system to demonstrate localization of expression of each
fluorescent protein. Other EBL cells captured at 5 h post-invasion
were negative for RFP expression yet were expressing GFP. This
suggested that all the internalised bacteria had been lysed and free
plasmid DNA had been delivered outside of the phagocytic
vacuoles. The 3D images showed localization of eukaryotic GFP
expression in the cytosol of the EBL cell.
The high level of bacterial invasion (10–47%) found in this work
and a previous study (7) indicates the potential of the system as a
delivery method for foreign antigens. However, differences in
behaviour are observed among attenuated bacterial strains in the
hostile environment inside mammalian cells. Bacteria such as S.
flexneri, L. monocytogenes or E. coli, carrying the virulence plasmid of
S. flexneri, invade their host cells and then escape from a vacuole
into the cytosol. Once in the cytosol they die, for example because
they are auxotrophic, conditionally express autolysins or are killed
by the addition of antibiotics to the cultures. This results in lysis of
the bacteria and release of the expression plasmids. Some of these
plasmids find their way into the nucleus where the open reading
frames are expressed under the control of the eukaryotic
transcription elements [16–19]. Bacteria such as S. typhimurium,
S. typhi or E. coli expressing the invasion gene, inv, of Y.
pseudotuberculosis, invade their host cells and remain in the vacuole.
There they die, for example due to metabolic attenuation, and
release their expression plasmids. By an unknown mechanism,
these plasmids cross the vesicular membrane and reach the cell
nucleus of the host cells where they are expressed [16,20,21]. Our
previous work showed by transmission electron microscopy that
invasive aroA P. multocida B:2 were confined to the vacuoles of EBL
cells and some internalised bacteria appeared to be ruptured and
in the process of degradation (7). Thus, it can be assumed that the
attenuated aroA mutant dies through metabolic attenuation and
then releases pSRG which must transfer from the vacuoles into the
cytoplasm and then be delivered to the nuclear compartment, by
an unknown mechanism. The above results have indicated that it
is possible to obtain efficient bactofection using P. multocida B:2.
However, in future work, more evidence of DNA transfer could
perhaps be obtained by demonstrating splicing of the plasmid-
encoded eukaryotic mRNA or expression in the presence of
antibiotics that block prokaryotic protein synthesis.
Figure 4 is a schematic diagram to model the bactofection
pathway of P. multocida B:2 JRMT12 pSRG after infection of EBL
cells and also incorporates some of the FM images obtained. In
Figure 4A, P. multocida B:2 JRMT12 pSRG is shown expressing
RFP before invading the EBL cells. At 3 h post-invasion, bacterial
RFP expression was seen intracellularly (Figures 4B & 4C). Some
infected cells harbouring viable P. multocida B:2 JRMT12 pSRG
expressing RFP also expressed GFP (Figures 4D & 4E). This
suggested that there was death of the bacteria from an early stage
of infection. At 5 h post-invasion, the majority of the GFP-
expressing cells were Pasteurella-negative (Figure 4F). In conclusion,
our ‘‘traffic-light’’ plasmid pSRG, encoding dual promoters
downstream of respective fluorescent reporters, represents a
convenient and useful tool for analysing the different steps of the
P. multocida B:2 infectious process by FM. Together with the live-
attenuated P. multocida B:2 strain JRMT12, it has the potential to
act as a vaccine, not only against HS, but also to provide immunity
to other diseases, by replacing the eukaryotic GFP reporter gene
with genes for protective antigens from other disease-causing
organisms. In this regard, it will be of considerable value in future
work to evaluate the persistence of GFP expression in EBL cells
and, more importantly, to assess the persistence of antigen
expression in vivo. In addition, our understanding of Pasteurella
infection could be broadened by live-cell imaging for better
visualization during time-course experiments and by flow-cytom-
etry to further evaluate how bacterial dosage relates to plasmid
delivery and protein expression.
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